See more : Downer EDI Ltd (DOW.AX) Income Statement Analysis – Financial Results
Complete financial analysis of China Regenerative Medicine International Limited (8158.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Regenerative Medicine International Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- TOMI Environmental Solutions, Inc. (TOMZ) Income Statement Analysis – Financial Results
- Aisin Corporation (ASEKY) Income Statement Analysis – Financial Results
- Atlas Cycles (Haryana) Limited (ATLASCYCLE.NS) Income Statement Analysis – Financial Results
- Outback Goldfields Corp. (OZ.V) Income Statement Analysis – Financial Results
- Glencore plc (GLCNF) Income Statement Analysis – Financial Results
China Regenerative Medicine International Limited (8158.HK)
About China Regenerative Medicine International Limited
China Regenerative Medicine International Limited, an investment holding company, produces and sells healthcare products and services. The company offers health management services, such as assessment of health situation, treatment for detox, balance of inner body, nourishing organs, and enhancement of immune system; and beauty services comprising non-surgical medical aesthetic services, basic skincare, solutions for youthful skin, hair revitalizing, lines firming, partial remodelling, and intimate repairing services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 69.49M | 231.61M | 282.90M | 185.34M | 47.97M | 72.95M | 755.52M | 356.99M | 27.75M | 2.82M | 510.00K | 1.38M | 128.00K | 2.62M | 30.00K | 24.45M | 88.76M | 64.95M | 42.43M | 20.57M |
| Cost of Revenue | 50.06M | 193.99M | 215.17M | 140.33M | 19.05M | 45.95M | 580.22M | 219.46M | 9.41M | 1.43M | 352.00K | 1.62M | 85.00K | 933.00K | 24.00K | 17.17M | 65.54M | 50.49M | 28.77M | 14.65M |
| Gross Profit | 19.42M | 37.62M | 67.73M | 45.01M | 28.92M | 27.01M | 175.30M | 137.53M | 18.34M | 1.39M | 158.00K | -238.00K | 43.00K | 1.69M | 6.00K | 7.28M | 23.22M | 14.46M | 13.66M | 5.92M |
| Gross Profit Ratio | 27.95% | 16.24% | 23.94% | 24.29% | 60.28% | 37.02% | 23.20% | 38.52% | 66.09% | 49.20% | 30.98% | -17.28% | 33.59% | 64.40% | 20.00% | 29.79% | 26.16% | 22.26% | 32.19% | 28.79% |
| Research & Development | 0.00 | 0.00 | 0.00 | 368.00K | 16.33M | 32.44M | 40.08M | 0.00 | 58.66M | 31.09M | 35.32M | 21.48M | 14.67M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 38.89M | 22.21M | 43.05M | 158.74M | 201.06M | 324.02M | 358.48M | 322.46M | 303.25M | 171.13M | 136.88M | 74.23M | 69.69M | 54.53M | 50.98M | 52.93M | 0.00 | 20.90M | 13.88M | 10.11M |
| Selling & Marketing | 6.64M | 3.60M | 4.39M | 26.64M | 56.26M | 134.70M | 133.91M | 66.80M | 33.08M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 45.54M | 25.82M | 47.45M | 185.38M | 257.32M | 458.71M | 404.19M | 389.26M | 303.25M | 171.13M | 136.88M | 74.23M | 69.69M | 54.53M | 50.98M | 52.93M | 0.00 | 20.90M | 13.88M | 10.11M |
| Other Expenses | 0.00 | 6.79M | -41.44M | -4.37M | -7.19M | -22.27M | 0.00 | 20.89M | 9.13M | 2.10M | 5.66M | 6.79M | -2.07M | -2.91M | -940.00K | -16.20M | 37.39M | -1.27M | 0.00 | 216.00K |
| Operating Expenses | 19.42M | 32.61M | 6.01M | 181.01M | 250.13M | 445.88M | 444.27M | 377.94M | 302.48M | 171.13M | 136.88M | 74.23M | 67.62M | 51.62M | 50.04M | 36.73M | 37.39M | 19.63M | 13.88M | 10.32M |
| Cost & Expenses | 178.61M | 226.60M | 221.18M | 321.34M | 269.18M | 491.83M | 1.02B | 597.40M | 311.89M | 172.56M | 137.23M | 75.85M | 67.70M | 52.55M | 50.06M | 53.90M | 102.93M | 70.12M | 42.65M | 24.97M |
| Interest Income | 12.00K | 1.00K | 11.00K | 23.00K | 415.00K | 7.03M | 21.95M | 20.13M | 109.56M | 1.73M | 0.00 | 0.00 | 0.00 | 0.00 | 35.00K | 110.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 979.00K | 781.00K | 736.00K | 18.52M | 5.34M | 21.65M | 0.00 | 24.43M | 25.83M | 3.06M | 2.53M | 1.69M | 1.54M | 2.59M | 38.96M | 6.74M | 196.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 11.32M | 5.39M | 78.00K | 1.73M | 51.69M | 69.60M | 61.38M | 55.28M | 51.89M | 48.98M | 30.46M | 18.64M | 17.72M | 17.03M | 18.49M | 9.47M | 1.68M | 645.00K | 646.00K | 637.00K |
| EBITDA | -95.40M | 14.44M | 64.66M | -122.46M | -267.63M | -1.26B | -159.00M | -131.21M | -113.59M | -220.61M | -242.25M | -49.04M | -49.85M | -32.90M | -52.01M | -27.68M | -12.49M | -5.75M | 422.00K | -3.76M |
| EBITDA Ratio | -137.30% | 3.80% | 22.86% | -68.21% | -359.48% | -776.83% | -27.48% | -40.37% | -409.20% | -6,356.48% | -47,500.39% | -3,561.37% | -38,945.31% | -1,255.28% | -36,933.33% | 111.96% | -14.08% | -6.96% | 0.99% | -18.30% |
| Operating Income | -109.12M | 8.62M | 64.59M | -128.14M | -224.14M | -636.41M | -268.97M | -199.39M | -165.45M | -228.04M | -272.72M | -67.68M | -67.57M | -49.93M | -29.57M | 17.90M | -14.17M | -5.17M | -224.00K | -4.40M |
| Operating Income Ratio | -157.04% | 3.72% | 22.83% | -69.14% | -467.24% | -872.37% | -35.60% | -55.85% | -596.19% | -8,095.07% | -53,473.73% | -4,915.03% | -52,790.63% | -1,904.96% | -98,550.00% | 73.22% | -15.96% | -7.96% | -0.53% | -21.39% |
| Total Other Income/Expenses | 1.42M | -3.54M | 2.66M | -135.93M | -182.34M | -933.92M | 11.23M | 29.49M | -25.75M | -44.49M | -138.53M | -1.69M | -1.54M | -2.59M | -10.81M | 46.69M | 8.95M | 4.31M | 2.00M | 912.00K |
| Income Before Tax | -107.70M | 8.27M | 64.29M | -277.33M | -456.64M | -1.35B | -257.74M | -210.92M | -191.20M | -272.53M | -275.25M | -69.37M | -69.11M | -52.52M | -81.28M | 11.16M | -3.24M | -860.00K | 1.78M | -3.49M |
| Income Before Tax Ratio | -154.99% | 3.57% | 22.73% | -149.63% | -951.92% | -1,854.37% | -34.11% | -59.08% | -688.98% | -9,674.41% | -53,970.20% | -5,038.05% | -53,993.75% | -2,003.85% | -270,923.33% | 45.64% | -3.65% | -1.32% | 4.19% | -16.96% |
| Income Tax Expense | 0.00 | 3.71M | 12.47M | 12.38M | -8.90M | -68.88M | -8.42M | -11.73M | 3.33M | -17.14M | -3.95M | -1.89M | -970.00K | -1.95M | -3.96M | 1.07M | 217.00K | -486.00K | -2.00M | -912.00K |
| Net Income | -107.70M | 4.56M | 51.83M | -289.71M | -447.74M | -1.19B | -237.74M | -184.50M | -190.90M | -250.10M | -263.44M | -61.32M | -57.11M | -42.06M | -64.57M | 21.09M | -3.46M | -374.00K | 1.78M | -3.49M |
| Net Income Ratio | -154.99% | 1.97% | 18.32% | -156.31% | -933.36% | -1,636.01% | -31.47% | -51.68% | -687.91% | -8,878.17% | -51,655.29% | -4,453.16% | -44,616.41% | -1,604.77% | -215,230.00% | 86.27% | -3.89% | -0.58% | 4.19% | -16.96% |
| EPS | -0.38 | 0.02 | 0.18 | -1.80 | -5.09 | -1.36 | -2.70 | -0.21 | -0.22 | -0.40 | -0.53 | -0.17 | -0.16 | -0.13 | -0.38 | 0.19 | -0.04 | 0.00 | 0.03 | -0.05 |
| EPS Diluted | -0.38 | 0.02 | 0.18 | -1.80 | -5.09 | -1.36 | -2.70 | -0.21 | -0.22 | -0.40 | -0.53 | -0.17 | -0.16 | -0.13 | -0.19 | 0.12 | -0.03 | 0.00 | 0.03 | -0.05 |
| Weighted Avg Shares Out | 286.41M | 285.43M | 285.43M | 160.68M | 87.93M | 879.29M | 87.93M | 879.37M | 865.47M | 620.13M | 493.79M | 370.48M | 352.84M | 328.93M | 170.71M | 109.10M | 92.38M | 76.55M | 67.63M | 68.20M |
| Weighted Avg Shares Out (Dil) | 286.41M | 285.43M | 285.43M | 160.68M | 87.93M | 879.29M | 87.93M | 879.37M | 865.47M | 620.13M | 493.79M | 370.48M | 352.84M | 328.93M | 333.28M | 218.49M | 105.18M | 76.55M | 67.63M | 68.20M |
Source: https://incomestatements.info
Category: Stock Reports